Respiratory Health Questions

Persistent cough (over 3 weeks), coughing up blood, breathlessness with activities you used to do easily, wheezing, chronic mucus production, recurrent chest infections, unexplained weight loss, fatigue, and chest pain. Any of these deserve medical evaluation. In India, persistent cough always warrants ruling out tuberculosis.

Aerobic exercise (walking, jogging, cycling, swimming) improves overall cardiopulmonary fitness. Breathing exercises (pranayama, diaphragmatic breathing) improve efficiency and are especially helpful for people with COPD or asthma. Playing wind instruments strengthens respiratory muscles. Stopping smoking is the biggest lung-health intervention. Lung capacity itself doesn't grow beyond genetic potential, but function within your capacity improves.

Not routinely for healthy asymptomatic adults. Useful if you have persistent respiratory symptoms, occupational exposure, long smoking history, or being evaluated for asthma or COPD. Spirometry is quick, painless, and provides genuine diagnostic information. A screening spirometry every few years can be reasonable for higher-risk individuals.

Fine particulate matter (PM2.5) is small enough to penetrate deep into lung tissue and even enter the bloodstream. Long-term exposure causes airway inflammation, reduced lung development in children, worse asthma control, higher COPD and lung cancer rates, and increased cardiovascular disease. Children and outdoor workers are most exposed. Effects accumulate over years, so annual peaks in polluted cities matter.

Good HEPA-filter purifiers with adequate CADR (clean air delivery rate) for the room size do reduce indoor PM2.5. Measurable benefit for children, asthmatics, and elderly in high-pollution cities. Not a substitute for outdoor measures (masks, avoiding outdoor exercise on bad AQI days) or systemic pollution reduction. A cheap small unit in a large room does little; matching capacity to room size matters.

Long-term exposure to high particulate matter (PM 2.5) increases risk of asthma, COPD, lung cancer, heart disease, and reduced lung function even in non-smokers. Delhi, Kolkata, and increasingly other cities regularly cross unhealthy levels. Protective measures: check daily AQI, use N95 masks outdoors on bad days, keep windows closed, indoor air purifiers for vulnerable people (children, asthmatics, elderly), and exercise indoors on high-pollution days.

See a doctor if a cough lasts more than 3 weeks, comes with unexplained weight loss, night sweats, blood in sputum, high fever, breathlessness, or chest pain. In India, persistent cough always needs to rule out tuberculosis. Cough that worsens at night in a child can suggest asthma. Sudden severe cough with breathlessness could be a foreign body or asthma attack.

Asthma typically causes recurrent episodes of wheezing, breathlessness, chest tightness, and cough — often worse at night, early morning, with exercise, allergens, or cold air. Diagnosis needs a lung function test (spirometry) — not just symptoms or a chest X-ray. Many people diagnosed as 'asthmatic' actually have allergic rhinitis, viral bronchitis, or GERD-related cough. A pulmonologist can sort out which.

No. Hookah/shisha exposes users to significant carbon monoxide, tar, and toxic chemicals — often more per session than a cigarette. Vaping is less harmful than cigarettes for existing smokers switching over, but not harmless — long-term effects are still being studied, and it's addictive. Neither is safe for non-smokers or young people to start.

Persistent cough (weeks not days), breathlessness with activities you used to do easily, wheezing, chest tightness, recurrent chest infections, unexplained weight loss, fatigue, and — later — blue-tinged fingertips or lips. Anyone with smoking history or significant pollution exposure should take these seriously. A spirometry test measures lung function and catches decline early.

Allergic rhinitis (from dust mites, pollen, mould, pet dander, cockroach droppings) is the most common cause. Non-allergic rhinitis from irritants, weather changes, or hormones is also common. Rarer: nasal polyps, deviated septum, chronic sinusitis. If symptoms persist most days for weeks, an ENT specialist or allergist can distinguish and guide treatment beyond over-the-counter antihistamines.

If symptoms are frequent, affecting sleep or quality of life, and unclear triggers — yes. Skin prick tests or specific IgE blood tests identify actual triggers. Random 'panel' tests without symptom correlation are often not useful. Testing is most helpful when it changes what you do (allergen avoidance strategy, targeted treatment, or immunotherapy consideration).

First line: nasal steroid sprays (fluticasone, budesonide) daily — often more effective than tablets. Add oral antihistamines for breakthrough symptoms. Avoiding triggers where possible (dust-proof pillow covers, keeping pets out of bedrooms, high-efficiency air purifier, wearing a mask outdoors during pollen season). For persistent severe symptoms, immunotherapy (allergy shots or drops) can gradually reduce sensitivity.

Cold: sudden onset with fever possible, thick coloured nasal discharge later, sore throat, resolves in 7-10 days. Allergic rhinitis: gradual, no fever, clear watery nasal discharge, itchy eyes/nose/throat, sneezing spells, can last weeks or seasons, often recurrent. Allergies are also often triggered by specific exposures (going outside, dust in the house, pet contact).

For dust mite, mould, pet dander, and outdoor pollution particles entering indoors: yes, HEPA-filter purifiers help — measurably so for larger units suited to room size. Not a substitute for allergen avoidance (dust-proof bedding, regular cleaning). Runs continuously in the room where you sleep for meaningful benefit. Cheap small units in large rooms don't do much.

For most adult-onset asthma, yes — but well-controlled asthma should not interfere with normal life, exercise, or sleep. Childhood asthma sometimes resolves or improves markedly in adulthood; other times it persists. The goal is good control (rare symptoms, no night-time waking, normal activity, normal lung function on testing) — not to 'cure' it.

Good control looks like: symptoms less than twice a week, no night-time waking from asthma, reliever inhaler needed less than twice a week, no limitation of activities. Poor control: frequent symptoms, night-time waking, frequent reliever use, missed work or school, hospital visits. If any of these describe you, your treatment needs adjustment — talk to your doctor rather than living with poor control.

For most people with persistent asthma: yes — a daily 'preventer' (usually inhaled corticosteroid) keeps airway inflammation down. Reliever inhalers (blue/salbutamol) are for quick symptom relief only. Over-reliance on relievers without preventer use is a common pattern — and dangerous, since it doesn't address the underlying inflammation. Combination inhalers (steroid + long-acting bronchodilator) are common maintenance.

Yes — inhaled steroids deliver very small doses directly to the airways and are safe for years of use in most people. Side effects (oral thrush, hoarse voice) are minor and preventable by rinsing your mouth after use. The risks of poorly controlled asthma (airway damage, life-threatening attacks) far outweigh the low risks of inhaled steroids. Don't stop them because you feel fine — feeling fine is the medicine working.

Individual triggers vary — common ones: allergens (dust mites, pollen, pet dander, mould, cockroaches), viral infections, cold air, exercise (though controlled asthma shouldn't prevent exercise), tobacco smoke, air pollution, strong fragrances, and — for some — aspirin/NSAIDs. Identify your own triggers by observation. Some triggers can be avoided; for others (pollution, cold air), pre-treatment with your inhaler before exposure helps.

Chronic obstructive pulmonary disease — a progressive lung condition causing airflow obstruction. Main causes: long-term smoking (biggest), long-term biomass fuel exposure (relevant in rural India where chulha smoke is a major cause, especially for women), long-term severe air pollution, and — less commonly — occupational dust or genetic factors (alpha-1 antitrypsin deficiency). Symptoms: progressive breathlessness, chronic cough, sputum production.

COPD is largely permanent airflow obstruction, typically in adults over 40 with a history of smoking or biomass exposure. Asthma is often reversible airflow obstruction, may start in childhood, often with allergic triggers, and lung function normalises between episodes. Some people have overlapping features (ACO — asthma-COPD overlap). Spirometry testing distinguishes them.

No — the lung damage doesn't reverse. But progression can be slowed dramatically by stopping smoking (or biomass exposure), taking prescribed inhalers, pulmonary rehabilitation (structured exercise programme), preventing infections through vaccinations, and treating exacerbations promptly. Even people with advanced COPD can significantly improve function and quality of life with proper care.

Long-acting bronchodilator inhalers (LABAs, LAMAs), inhaled corticosteroids for some, pulmonary rehabilitation (structured exercise proven to improve breathlessness), vaccinations (flu, pneumococcal, COVID), oxygen therapy for advanced cases, and — for a small subset — lung volume reduction or transplant. Stopping smoking is the single most impactful intervention at any stage.

Worsening breathlessness despite reliever use, increased sputum production or change to green/yellow, fever, chest pain, extreme fatigue, confusion, or blue-tinged lips or fingertips — all warrant urgent evaluation. Sudden severe attacks are dangerous. A home oxygen monitor (pulse oximeter) is useful for people with COPD; oxygen saturation dropping below 90% needs medical attention.

Sleep apnea is repeated pauses in breathing during sleep — most commonly from throat tissue collapse (obstructive sleep apnea). Signs: loud snoring, gasping or choking during sleep, waking unrefreshed, daytime sleepiness, morning headaches, mood changes. Left untreated, it raises risk of hypertension, heart disease, stroke, diabetes, and accidents from daytime fatigue. Very common in India — especially in men with abdominal obesity.

A sleep study (polysomnography, or a simpler home sleep test) is the diagnostic test. Your partner's observations are often the first clue — loud snoring with pauses, or gasping episodes. Excessive daytime sleepiness, morning headaches, and poor concentration warrant evaluation. Not everyone who snores has sleep apnea, but sleep apnea usually causes snoring.

Continuous Positive Airway Pressure — a machine that keeps airways open with gentle pressurised air through a mask during sleep. It's the most effective treatment for moderate-severe obstructive sleep apnea. Adherence is the biggest challenge — the mask takes getting used to. Modern machines are quiet and small. Most people who stick with it feel dramatically better within weeks.

For obesity-related sleep apnea (very common), losing 10-15% of body weight often significantly improves or even resolves sleep apnea. Doesn't work for everyone or every form of sleep apnea (some have anatomical causes). Weight loss should be alongside — not instead of — treating current sleep apnea, since untreated sleep apnea makes weight loss harder (poor sleep disrupts appetite hormones).

Weight loss, avoiding alcohol close to bedtime (relaxes throat muscles), avoiding sedatives, sleeping on your side (positional therapy) rather than back, treating nasal congestion, and quitting smoking (reduces upper airway inflammation). These help but usually don't replace CPAP for moderate-severe cases. Sleep hygiene (consistent schedule, dark cool room, no screens before bed) helps sleep quality generally.

The most successful approach combines behavioural support (counselling, quit apps, quit-lines) with medication (nicotine replacement — patches, gum, lozenges; or prescription drugs like varenicline or bupropion). India's national tobacco quit-line (1800-11-2356) is free. Willpower alone has under 5% quit rates; combined approaches reach 25-30% one-year quit rates. Multiple attempts are normal — each attempt increases eventual success.

For existing smokers who can't quit with proven methods, switching to vaping is likely less harmful than continuing cigarettes — but not harmless. Vapes are addictive, and long-term effects are still being studied. India has banned e-cigarettes, limiting availability. Better path: use approved nicotine replacement (patches, gum) plus counselling. Don't take up vaping if you don't already smoke.

Fast. Within 20 minutes: heart rate drops. Within 24 hours: carbon monoxide levels normalise. 2 weeks-3 months: circulation and lung function improve, exercise gets easier. 1 year: heart disease risk drops significantly. 5-10 years: lung cancer risk falls to about half a smoker's. 15 years: heart disease risk approaches non-smoker. Every day quit adds up.

Many people gain 3-5 kg on average — nicotine suppresses appetite and mildly raises metabolism. Some gain more. The health benefit of quitting vastly exceeds the harm from moderate weight gain — this shouldn't stop you quitting. Prepare with a plan: healthier snacks handy, regular activity during the quit window, and staying hydrated. Weight gain slows and often reverses over 6-12 months.

Neither is easier; both are strongly addictive. Chewing tobacco (gutka, khaini, zarda, paan with tobacco) is often more addictive per exposure because delivery is prolonged. Same evidence-based approach applies — behavioural support plus nicotine replacement or medication. India has particularly high oral cancer rates from chewing tobacco; quitting reduces risk substantially, especially in the first 5-10 years.

The sweat test (pilocarpine iontophoresis) is the gold standard for CF diagnosis. In CF, the defective CFTR protein cannot properly regulate chloride channels in sweat gland cells — so sweat contains abnormally high chloride levels. The test: a small electric current stimulates sweat production at the wrist or forearm; sweat is collected on gauze for 30 minutes; chloride level is measured. Results: normal <30 mmol/L; borderline 30–59 mmol/L; positive for CF ≥60 mmol/L. Accuracy is high — sensitivity and specificity both above 95% when properly performed. Where it fits in the diagnostic pathway: Newborn screening in India (where available) detects elevated blood immunoreactive trypsinogen (IRT) — a flag, not a diagnosis. Sweat test then confirms. Genetic testing identifies the specific CFTR mutations, which matters for treatment (some CFTR modulators only work on specific mutation classes). In India, newborn screening is available in many private hospitals and some state government programmes (Tamil Nadu, Maharashtra have expanded screening). Sweat testing is available at paediatric tertiary centres — AIIMS Delhi, Manipal, Christian Medical College Vellore, Rainbow Hospital Hyderabad. CF is underdiagnosed in India — many children are diagnosed years after symptom onset because TB or recurrent pneumonia is initially suspected instead.

Fluids first — aim for at least 2–2.5 litres/day: warm water, fresh vegetable soups (dal water, bottle gourd/lauki soup), coconut water, and warm herbal teas (ginger-tulsi, mulethi/licorice root). These thin mucus and support expectoration. For food: prioritise protein-rich meals (dal, eggs, curd, paneer, fish) because your immune system needs amino acids for antibody production and tissue repair. Vitamin C-rich foods (amla, guava, orange, lemon) support white blood cell function. Zinc from pumpkin seeds, legumes, and whole grains reduces inflammation. What to avoid: heavy, oily, or fried food (hard to digest when already oxygen-compromised), alcohol (dehydrates and suppresses immune response), and cold drinks or ice cream (may aggravate coughing). Small frequent meals are better than three large ones — diaphragm pressure after a full meal can worsen breathlessness.

Most healthy adults with mild to moderate community-acquired pneumonia feel meaningfully better within 5–7 days of starting antibiotics. However, full recovery — returning to normal energy levels without breathlessness — typically takes 3–6 weeks. A useful rule: fever and productive cough should begin improving by Day 3–5. If they don't, that's a sign the treatment isn't working or the pathogen isn't responding — go back to your doctor. X-ray clearance takes longer than symptom clearance — a chest X-ray often still shows infiltrates at 6–8 weeks even when a patient feels well. Older adults (65+), people with diabetes or COPD, and smokers typically recover more slowly. For this group, doctor-monitored home recovery with a follow-up appointment at 2 weeks is the standard approach.

Seven warning signs require same-day emergency care — do not wait until morning: (1) breathing rate faster than 30 breaths per minute at rest; (2) lips, fingernails, or skin turning bluish (cyanosis) — indicates critically low oxygen; (3) confusion, extreme drowsiness, or altered consciousness, especially in elderly patients; (4) SpO2 below 92% on pulse oximeter at home; (5) inability to keep fluids down due to vomiting (antibiotic medication can't be retained); (6) no improvement after 48–72 hours on prescribed antibiotics; (7) severe chest pain making normal breathing impossible. In India, call 108 (national ambulance service) or take the patient to the nearest government hospital emergency immediately. Do not apply steam or give home remedies in this state — these are signs of severe pneumonia (CURB-65 score 3+) that can deteriorate rapidly without IV antibiotics and oxygen.

Incentive spirometry (IS) is a breathing device that provides visual feedback to encourage deep inhalation — the goal is to recruit collapsed alveoli (atelectasis) and mobilise secretions. Technique: (1) Ensure the patient is sitting upright (Fowler's 60–90°) or at least at 30–45°; (2) The patient seals their lips around the mouthpiece; (3) Breathe in slowly and deeply to raise the piston/ball to the target level — slow inhalation (over 5 seconds) is more effective than rapid; (4) Hold the breath for 5–10 seconds at maximum inhalation; (5) Exhale through pursed lips; (6) Repeat 10 repetitions per hour while awake. Common errors to correct: patients try to exhale through the device (it only measures inhalation), or they inhale too rapidly (the piston rises but lung expansion is incomplete). Controlled coughing (huffing technique): after 3 IS repetitions, use the huff technique — take a medium breath, hold for 2 seconds, then open the mouth and exhale with a 'huff' sound (like fogging a mirror) 2–3 times without straining the throat. This is more effective than forced coughing for moving secretions from lower airways to upper airways where they can be expectorated. Contraindication notes: IS and coughing exercises may increase pain after thoracic surgery — ensure adequate analgesia before the session; patients with rib fractures or recent abdominal surgery need modified technique or splinting with a pillow over the incision during the huff. Goal: in a pneumonia patient, secretion clearance is the primary objective — track whether sputum production changes (color, volume) across sessions and document findings.

Empiric antibiotic selection depends on severity (CURB-65) and whether the patient has comorbidities. Standard CAP (CURB-65 0–2, no comorbidities): amoxicillin 500 mg TID orally (first-line for typical bacterial pneumonia) or doxycycline (if atypical organisms — Mycoplasma, Legionella — suspected); azithromycin 500 mg OD for 5 days is an alternative for atypicals. Moderate-severe CAP (hospital, CURB-65 ≥2): combination of a beta-lactam (amoxicillin-clavulanate or ceftriaxone IV) + a macrolide (azithromycin), covering both typical and atypical organisms. India-specific note: TB must always be in the differential for a consolidation that doesn't respond to 48–72 hours of antibiotics — a non-resolving infiltrate with productive cough and weight loss needs AFB sputum before antibiotics are escalated. HAP (hospital-acquired pneumonia, onset >48 hours post-admission): higher suspicion for MRSA and gram-negative rods (Klebsiella, Pseudomonas in ICU settings); empiric piperacillin-tazobactam or meropenem may be needed pending culture. Nursing monitoring responsibilities: (1) temperature chart Q4H — fever resolution by 48–72 hours is expected with appropriate antibiotics; failure to defervesce signals wrong organism or resistant pathogen; (2) sputum culture result review — report to prescriber if organism identified; (3) IV antibiotic timing — maintain scheduled intervals (never cluster doses); (4) IV site assessment daily for phlebitis; (5) renal function monitoring in patients on aminoglycosides (if used). Antibiotic de-escalation: if cultures return sensitive organisms, nursing should prompt prescriber review to narrow coverage — broad-spectrum antibiotics maintained longer than necessary increase C. diff risk.

CURB-65 assigns 1 point each for: Confusion (new onset, AMTS ≤8); Urea >7 mmol/L (or BUN >19 mg/dL); Respiratory rate ≥30/min; Blood pressure systolic <90 or diastolic ≤60 mmHg; age ≥65 years. Score interpretation: 0–1: low severity — consider home treatment with close GP follow-up; 2: moderate — hospital admission advised; 3–5: high severity — consider ICU or HDU assessment. The score guides triage, but nursing assessment adds information the score can't capture: SpO2 trajectory (dropping despite O2), work of breathing (accessory muscle use, tripod positioning), mental status changes in the preceding hours, and oral intake. A CURB-65 of 2 in an elderly patient with poor oral intake, declining SpO2 on room air, and unable to take oral antibiotics reliably warrants admission regardless of the number. ICU triggers from a nursing escalation standpoint: SpO2 <90% on ≥4 LPM O2, RR >30 and not responding to treatment, new confusion, hypotension not resolved by fluids, or bilateral consolidation on CXR. Use SBAR format for escalation: Situation (patient X, admitted with CAP, CURB-65 2), Background (comorbidities, day of illness), Assessment (SpO2 dropping to 88% despite 6LPM O2, increasing respiratory rate), Recommendation (review for ICU/HDU step-up). In India, CURB-65 is taught at most nursing colleges but frequently underused on wards — build it into the admission nursing note as a scored checkbox.

Home ventilation (usually non-invasive BiPAP for chronic respiratory failure) requires: (1) family caregiver trained on mask fitting, alarms, and backup power; (2) monthly equipment cleaning and filter changes; (3) daily SpO2 checks and symptom review; (4) 24/7 emergency contact with the pulmonology team; (5) medication reconciliation to avoid respiratory depressants. Bedsore prevention with 2-hourly repositioning, aspiration precautions, and nutrition monitoring (many home-vent patients need PEG feeds) are essential. Coordinate with a home-care nursing service for weekly reviews in the first month.

VAP is the most common ventilator complication, affecting up to 20% of ventilated patients. Prevention bundle (evidence-based): (1) elevate head of bed 30–45 degrees unless contraindicated; (2) daily sedation interruption and readiness-to-extubate assessment; (3) subglottic secretion drainage for tubes >48 hours; (4) oral care with chlorhexidine every 4 hours; (5) DVT and stress-ulcer prophylaxis. Consistent bundle application reduces VAP rates by 40–60% per published ICU quality data.

Ineffective airway clearance (NANDA 00031) is the most common primary nursing diagnosis for cough across COPD, pneumonia, and post-operative patients. Three evidence-based interventions that make the most difference: (1) Controlled coughing technique — teach the patient to take 2-3 slow diaphragmatic breaths, then cough twice with the mouth slightly open while bracing the abdomen; this is more effective than repeated hacking coughs that fatigue respiratory muscles. (2) High Fowler's positioning (60–90°) — gravity-assisted drainage reduces mucus pooling; for unilateral lung disease, position the affected side up to drain secretions toward the bronchus. (3) Hydration target 2–2.5 L/day (unless cardiac or renal restriction) — adequate hydration reduces mucus viscosity by 30–40%, making airway clearance significantly easier. For patients who cannot clear secretions independently, nasopharyngeal suctioning may be ordered. Document secretion characteristics, quantity, and cough effort before and after each shift.

Six red-flag patterns require same-shift escalation, not waiting for rounds: (1) SpO2 dropping below 92% despite supplemental oxygen or position change; (2) haemoptysis — any frank blood in sputum, even small volume, needs same-day workup (TB, malignancy, PE); (3) sudden onset of high fever (>38.5°C) with productive cough + pleuritic chest pain suggesting new pneumonia or empyema; (4) respiratory rate >24/min persistently with accessory muscle use — impending respiratory failure; (5) altered consciousness or confusion in an elderly patient with cough — may indicate sepsis from pneumonia; (6) sudden relief of chronic cough with new haemoptysis or weight loss — raises concern for lung malignancy or TB reactivation. In any of these, document vital signs, current SpO2, mental status, and secretion characteristics before calling. SBAR format (Situation-Background-Assessment-Recommendation) is recommended for escalation communication in most Indian hospital settings.

Four things that directly reduce readmission: (1) Inhaler technique — if discharged on a bronchodilator or inhaled corticosteroid, have the patient demonstrate technique before leaving. Studies show >60% of patients use inhalers incorrectly at home, rendering medication ineffective. Use a spacer for all metered-dose inhalers in children and elderly. (2) Smoking cessation — if the patient smokes, every hospitalisation is a teachable moment. Provide Quitline India (1800-112-356, free) or Nicotine Replacement Therapy counselling. Even a 5-minute NRT conversation at discharge improves quit rates. (3) Return-to-ED criteria — write it down: seek emergency care if breathing becomes fast or laboured, lips turn blue, cough produces blood, or fever returns above 38.5°C. Verbal instructions alone are retained at <30% after discharge. (4) Vaccination follow-up — if patient was not vaccinated against flu or pneumococcus, remind them to get both within 2–4 weeks of recovery. Both are covered free at government hospitals under UIP for eligible groups (elderly, COPD, immunocompromised).

This is one of the most clinically important nursing considerations in COPD oxygen management. The concern: in healthy individuals, the respiratory drive is primarily driven by rising CO2 levels (hypercapnic drive). In some patients with severe COPD who chronically retain CO2 (type 2 respiratory failure, confirmed by ABG with elevated PaCO2), the body adapts by reducing sensitivity to CO2 and instead relying partly on low oxygen levels (hypoxaemic drive) to maintain respiratory effort. Giving high-flow oxygen to these patients can paradoxically reduce respiratory rate and worsen CO2 retention — potentially causing respiratory failure. However, this concern is frequently overapplied: the hypercapnic drive is primarily relevant in patients with confirmed chronic hypercapnia (PaCO2 >6 kPa on ABG during a stable period) — not all COPD patients have this. Overcorrecting the other way and not giving enough oxygen to hypoxaemic COPD patients also causes harm. Current GOLD guidelines and BTS Emergency Oxygen Guidelines recommend: Target SpO2 88–92% for COPD patients at risk of hypercapnia (GOLD 3–4, known CO2 retainers, or any COPD patient if ABG status unknown). Achieve this with 24–28% Venturi mask (provides precise FiO2) rather than simple face mask (which delivers variable oxygen concentration depending on flow and respiratory rate). If using a nasal cannula: 1–2 LPM typically achieves 88–92% in stable severe COPD; titrate by SpO2. Never withhold oxygen from a severely hypoxaemic COPD patient in acute distress — hypoxia kills faster than hypercapnia in acute settings; give controlled O2 and monitor closely. Document the prescribed SpO2 target (e.g., 'O2 to maintain SpO2 88–92%') clearly on the drug chart and nursing care plan — this prevents well-meaning staff from increasing flow because SpO2 looks 'low' to them.

A written COPD action plan is one of the highest-impact nursing interventions — studies show it reduces hospitalisation by 40% and improves patient self-efficacy. The traffic-light framework makes it actionable at home. Green zone (baseline — I feel like myself): usual symptoms, usual activity tolerance, SpO2 at personal baseline (establish this with a pulse oximeter during a stable week), sputum colour usual (clear/white). Action: continue all usual medications. Yellow zone (getting worse — something has changed): increased breathlessness from baseline, increased sputum volume or colour change (yellow/green signals bacterial infection), new or worsening wheeze, needing rescue inhaler more than 4 times/day, SpO2 dropped 3–4% from personal baseline. Action: start the COPD antibiotic (pre-prescribed — typically amoxicillin 500 mg TID or doxycycline 100 mg BD for 5–7 days) AND/OR prednisolone 30 mg for 5 days (pre-prescribed rescue pack); contact GP/pulmonologist within 24–48 hours. Red zone (emergency): severe breathlessness at rest or on minimal exertion, unable to complete sentences, SpO2 <88%, cyanosis, confusion, chest pain, or not improving after 24 hours of yellow-zone treatment. Action: call 108 ambulance or go to emergency department immediately; do not wait. Nursing role in implementing this: write the action plan in simple language with the patient's specific baseline values; give a laminated copy to the patient and one for each family member present; teach the family member to recognise red zone independently because a hypercapnic COPD patient may be too confused to self-escalate. In India: most public-sector hospitals do not routinely provide written action plans — this is a high-value gap that nurses in any setting can close.

Activity Intolerance is universal in moderate-to-severe COPD, but patients often respond to it by avoiding all activity — which accelerates deconditioning and worsens dyspnoea on the next attempt. The nursing goal is to break the dyspnoea-inactivity spiral with concrete energy conservation techniques. The 4-Ps framework works well for patient education: Prioritise — rank daily activities by importance; the non-negotiables (hygiene, one meaningful activity) get energy first; lower-priority tasks can be delegated or done less frequently. Pace — build in planned rest before the activity gets difficult, not after breathlessness starts; rest before breathlessness is prevention, rest after breathlessness is recovery (takes longer). Plan — do the hardest activities when energy is highest (usually mid-morning after bronchodilator has kicked in and before afternoon fatigue sets in); avoid activities within 1 hour after meals (diaphragm compressed by full stomach). Position — use position to reduce work of breathing: forward lean with elbows on knees or a table (tripod position) reduces accessory muscle work and mechanically improves diaphragm efficiency; pursed-lip breathing during any activity adds back-pressure to keep airways open. Specific techniques for common activities: bathing — sit on a bath stool, use a long-handled sponge; drying — use a towelling robe rather than towelling; getting dressed — put socks and shoes on while seated leaning forward. Breathlessness target: teach patients to exercise/move at an intensity where they can still speak in short phrases but not full sentences — this is roughly 40–60% of VO2 max, the safe pulmonary rehab intensity for most COPD patients. 6MWT improvement after pulmonary rehabilitation is typically 30–50 metres — clinically meaningful to patients.